SEC Filing Document

Company: DUKE Robotics Corp.
Ticker: DUKR
CIK: 1638911
Filing Type: S-1/A
Document Type: EX-1.1
Date Filed: 2026-04-27
Accession Number: 0001213900-26-048102
Exchange: OTC
SIC Code: 3721
SIC Description: Aircraft
URL: https://www.sec.gov/Archives/edgar/data/1638911/000121390026048102/ea028763601ex1-1.htm

Chunk 13 of 21
Word Count: 1354
Character Count: 8698

Document Content:

statement filed by the Company under the Securities Act. Documents filed with the Commission pursuant to its EDGAR system shall be deemed to have been delivered to the Underwriters pursuant to this Section. (b) Transfer Sheets. For a period of one (1) year from the Execution Date, the Company shall retain the Transfer Agent or a transfer and registrar agent acceptable to the Representative and will furnish to the Underwriters at the Company’s sole cost and expense such transfer sheets of the Company’s securities as an Underwriter may reasonably request, including the daily and monthly consolidated transfer sheets of the Transfer Agent and the DTC. (c) Trading Reports. For a period of one year from the Execution Date, the Company shall provide to the Underwriters, at the Company’s expense, such reports published by the Trading Market relating to price and trading of such securities, as the Underwriters shall reasonably request.

(d) General
Expenses Related to the Offering. The Company hereby agrees to pay on each of the Closing Date and each Option Closing Date, if any,
to the extent not paid at the Closing Date, all expenses incident to the performance of the obligations of the Company under this Agreement,
including, but not limited to: (a) all filing fees and communication expenses relating to the registration of the Public Securities to
be sold in the Offering (including the Option Securities) and the Representative’s Securities with the Commission; (b) all FINRA
Public Offering Filing System fees associated with the review of the Offering by FINRA; all fees and expenses relating to the listing
of such Closing Shares, Option Shares and Warrant Shares on the Trading Market and such other stock exchanges as the Company and the Representative
together determine; (c) all fees, expenses and disbursements relating to the registration or qualification of such Securities and the
Underwriter’s under the “blue sky” securities laws of such states and other foreign jurisdictions as the Representative
may reasonably designate; (d) the costs of all mailing and printing of the underwriting documents (including, without limitation, the
Underwriting Agreement, any Blue Sky Surveys and, if appropriate, any Agreement Among Underwriters, any agreements with Selected Dealers,
Underwriters’ Questionnaire and Power of Attorney), Registration Statements, Prospectuses and all amendments, supplements and exhibits
thereto and as many preliminary and final Prospectuses as the Representative may reasonably deem necessary; (e) the costs of preparing,
printing and delivering the Securities; (f) fees and expenses of the Transfer Agent for the Securities (including, without limitation,
any fees required for same-day processing of any instruction letter delivered by the Company); (g) stock transfer and/or stamp taxes,
if any, payable upon the transfer of securities from the Company to the Underwriters; (h) the fees and expenses of the Company’s
accountants; (i) the fees and expenses of the Company’s legal counsel and other agents and representatives; (j) the Underwriters’
costs of mailing prospectuses to prospective investors; (k) all fees, expenses and disbursements relating to background checks of the
Company’s officers and directors; (1) the fees and expenses associated with the Underwriters’ use of the Ipreo and NewRoadshow
(or other similar software) for the Offering; and (m) the Company’s actual “road show” expenses for the Offering. The
Underwriters may also deduct from the net proceeds of the Offering payable to the Company on the Closing Date, or each Option Closing
Date, if any, all out-of-pocket fees, expenses and disbursements (including legal fees and expenses) of the Underwriters incurred as a
result of providing services related to the Offering to be paid by the Company to the Underwriters. For the sake of clarity, it is understood
and agreed that (i) except as otherwise set forth herein, the Company shall be responsible for the Representative’s legal fees,
costs and expenses in connection with the Offering irrespective of whether the Offering is consummated, and (ii) the maximum amount of
all legal fees, costs and expenses incurred by the Representative pursuant to the Offering that the Company shall be responsible for shall
not exceed $125,000 in the event of a Closing, and shall not exceed $40,000 (of which $15,000 has been paid as an advance prior to the
Execution Date) in the event there is not a Closing.

4.7 Application
of Net Proceeds. The Company will apply the net proceeds from the Offering received by it in a manner consistent with the application
described under the caption “Use of Proceeds” in the Prospectus.

4.8 Delivery
of Earnings Statements to Security Holders. The Company will make generally available to its security holders as soon as practicable,
but not later than the first day of the fifteenth full calendar month following the Execution Date, an earnings statement (which need
not be certified by independent public or independent certified public accountants unless required by the Securities Act or the rules
and regulations under the Securities Act, but which shall satisfy the provisions of Rule 158(a) under Section 11(a) of the Securities
Act) covering a period of at least twelve consecutive months beginning after the Execution Date. For the avoidance of doubt, documents
filed with the Commission pursuant to its EDGAR system that contain the earnings statements required by this Section 4.8 shall be deemed
to have been delivered to security holders and satisfy the requirements of this Section 4.8.

4.9 Stabilization.
Neither the Company, nor, to its knowledge, any of its employees, directors or shareholders (without the consent of the Representative)
has taken or will take, directly or indirectly, any action designed to or that has constituted or that might reasonably be expected to
cause or result in, under the Exchange Act, or otherwise, stabilization or manipulation of the price of any security of the Company to
facilitate the sale or resale of the Securities.

4.10 Internal
Controls. For a period of three (3) years from the Effective Date, the Company shall maintain a system of internal accounting controls
sufficient to provide reasonable assurances that: (i) transactions are executed in accordance with management’s general or specific
authorization; (ii) transactions are recorded as necessary in order to permit preparation of financial statements in accordance with GAAP
and to maintain accountability for assets; (iii) access to assets is permitted only in accordance with management’s general or specific
authorization; and (iv) the recorded accountability for assets is compared with existing assets at reasonable intervals and appropriate
action is taken with respect to any differences.

4.11 Accountants.
For a period of three (3) years from the Effective Date, the Company shall continue to retain an independent PCAOB registered public accounting
firm. The Underwriters acknowledge that the Auditor is acceptable to the Underwriters.

4.12 FINRA.
The Company shall advise the Underwriters (who shall make an appropriate filing with FINRA) if it is aware that any officer, director,
5% or greater shareholder of the Company or Person that received the Company’s unregistered equity securities in the past 180 days
is or becomes an affiliate or associated person of a FINRA member firm prior to the earlier of the termination of this Agreement or the
conclusion of the distribution of the Offering.

Fiduciary Duties. The Company acknowledges and agrees that the Underwriters’ responsibility to the Company is solely contractual
and commercial in nature, based on arms-length negotiations and that neither the Underwriters nor their affiliates or any selected dealer
shall be deemed to be acting in a fiduciary capacity, or otherwise owes any fiduciary duty to the Company or any of its affiliates in
connection with the Offering and the other transactions contemplated by this Agreement. Notwithstanding anything in this Agreement to
the contrary, the Company acknowledges that the Underwriters may have financial interests in the success of the Offering that are not
limited to the difference between the price to the public and the purchase price paid to the Company by the Underwriters for the shares
and the Underwriters have no obligation to disclose, or account to the Company for, any of such additional financial interests. The Company
hereby waives and releases, to the fullest extent permitted by law, any claims that the Company may have against the Underwriters with
respect to any breach or alleged breach of fiduciary duty by the Underwriters.